.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

eP064

Auftreten eines subakut kutanen Lupus erythematodes unter Therapie mit dem Anti-PD-1-Antikörper Cemiplimab

Presented in

Session 2.2 – Non Melanoma Skin Cancer: PEK und BCC

Poster topics

Session 2.2 – Non Melanoma Skin Cancer: PEK und BCC

Authors

Dr. Simon Fietz (Bonn), Dr. Anne Fröhlich (Bonn), Dr. Judith Sirokay (Bonn), Prof. Jörg Wenzel (Bonn), Dr. Luka de Vos (Bonn), Dr. Tanja Fetter (Bonn), PD Dr. Philipp Jansen (Bonn), Prof. Dr. Jennifer Landsberg (Bonn), Dr. Friederike Hoffmann (Bonn)